Integrated Advisors Network LLC Abb Vie Inc. Transaction History

Integrated Advisors Network LLC

$2.14 Billion
Q2 2025

A detailed history of Integrated Advisors Network LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Integrated Advisors Network LLC holds 36,831 shares of ABBV stock, worth $7.32 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

36,831

Previous 53,458 31.1%

Holding current value

$7.32 Million

Previous $11.2 Million 38.96%

% of portfolio

0.32%

Previous 0.58%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$170.16 - $206.27 $2.83 Million - $3.43 Million	-16,627 Reduced 31.1%	36,831 $6.84 Million
Q1 2025 Apr 15, 2025	BUY	$169.2 - $216.66 $1.84 Million - $2.35 Million	10,856 Added 25.48%	53,458 $11.2 Million
Q4 2024 Feb 25, 2025	BUY	$164.99 - $203.87 $34,317 - $42,404	208 Added 0.49%	42,602 $7.57 Million
Q3 2024 Oct 24, 2024	SELL	$163.84 - $199.33 $456,130 - $554,934	-2,784 Reduced 6.16%	42,394 $8.37 Million
Q2 2024 Aug 09, 2024	SELL	$154.79 - $180.76 $97,208 - $113,517	-628 Reduced 1.37%	45,178 $7.75 Million
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $33,082 - $37,694	-207 Reduced 0.45%	45,806 $8.34 Million
Q4 2023 Feb 26, 2024	SELL	$137.6 - $154.97 $157,414 - $177,285	-1,144 Reduced 2.43%	46,013 $7.13 Million
Q3 2023 Nov 16, 2023	BUY	$133.59 - $154.65 $81,623 - $94,491	611 Added 1.31%	47,157 $7.03 Million
Q2 2023 Jul 14, 2023	BUY	$132.51 - $164.9 $129,992 - $161,766	981 Added 2.15%	46,546 $6.27 Million
Q1 2023 May 05, 2023	SELL	$144.61 - $166.54 $3.45 Million - $3.97 Million	-23,864 Reduced 34.37%	45,565 $7.26 Million
Q4 2022 Feb 02, 2023	BUY	$138.31 - $165.87 $9.6 Million - $11.5 Million	69,429 New	69,429 $11.2 Million
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $2.63 Million - $3.02 Million	-19,591 Reduced 25.32%	57,775 $7.75 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $150,831 - $191,756	-1,096 Reduced 1.4%	77,366 $11.8 Million
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $278,213 - $345,185	2,108 Added 2.76%	78,462 $12.7 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $265,781 - $336,290	2,474 Added 3.35%	76,354 $10.3 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $406,341 - $461,258	3,819 Added 5.45%	73,880 $7.97 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $300,374 - $334,634	2,855 Added 4.25%	70,061 $7.89 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $558,762 - $615,130	5,462 Added 8.85%	67,206 $7.27 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $708,392 - $956,404	8,801 Added 16.62%	61,744 $6.62 Million
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $764,513 - $897,286	-8,899 Reduced 14.39%	52,943 $4.64 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $792,836 - $1.06 Million	-10,806 Reduced 14.87%	61,842 $6.07 Million
Q1 2020 May 06, 2020	BUY	$64.5 - $97.79 $1.19 Million - $1.81 Million	18,482 Added 34.12%	72,648 $5.54 Million
Q4 2019 Feb 06, 2020	BUY	$72.13 - $90.25 $3.91 Million - $4.89 Million	54,166 New	54,166 $4.8 Million

Others Institutions Holding ABBV

# of Institutions

4,255

Shares Held

1.28B

Call Options Held

16.1M

Put Options Held

14.9M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $351B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Advisors Network LLC with notifications on news.

Account

Integrated Advisors Network LLC Abb Vie Inc. Transaction History